IGC Pharma extends $12M credit facility with O-Bank, facility fee rises 25%
Filed June 8, 2026 · Period ending June 5, 2026 · ~1 min read
Key Changes
-
medium
IGC extended its $12 million credit facility with Taiwan-based O-Bank for another year. The facility fee increased from $48,000 to $60,000 (up 25%), while all other material terms remain unchanged from the 2025 agreement.
Item 1.01 verify on EDGAR → -
medium
The extension creates a direct financial obligation for the company, maintaining IGC's access to working capital through its Taiwan banking relationship established in June 2025.
Item 2.03 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (HOTH 10-Q) is open in full — no account needed.
Partner
Trade IGC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 10, 2026 4:41 PM